In 2008 was created Inveready Technology Investment Group, which is appeared as VC. The leading representative office of defined VC is situated in the Barcelona. The company was established in Europe in Spain.
The higher amount of exits for fund were in 2019. The fund is constantly included in 7-12 investment rounds annually. This Inveready Technology Investment Group works on 13 percentage points less the average amount of lead investments comparing to the other organizations. Considering the real fund results, this VC is 27 percentage points more often commits exit comparing to other organizations. The top activity for fund was in 2016. The usual things for fund are deals in the range of 1 - 5 millions dollars.
The fund has no exact preference in some founders of portfolio startups. If startup sums 5+ of the founder, the chance for it to be financed is low. Among the most successful fund investment fields, there are Health Care, Biotechnology. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. For fund there is a match between the location of its establishment and the land of its numerous investments - Spain. Among the most popular portfolio startups of the fund, we may highlight Minoryx Therapeutics, Bitext, SamyRoad.
The typical case for the fund is to invest in rounds with 1-2 participants. Despite the Inveready Technology Investment Group, startups are often financed by Wayra, The Crowd Angel, Media Digital Ventures. The meaningful sponsors for the fund in investment in the same round are Sabadell Venture Capital, Bankinter, The Crowd Angel. In the next rounds fund is usually obtained by EASME - EU Executive Agency for SMEs, Caixa Capital Risc, Media Digital Ventures.
The overall number of key employees were 11.
| Fund Name | Location |
| API | Gifu, Gifu Prefecture, Japan |
| CDG Capital | Morocco, Rabat, Rabat-Sale-Zemmour-Zaer |
| eWTP Technology & Innovation Fund | China, Hangzhou, Zhejiang |
| Fidelity Canada | Canada, Ontario, Toronto |
| Good Energies | New York, New York, United States |
| HNC Software Inc | California, San Diego, United States |
| Hypothesis | - |
| Intuit Prosperity Accelerator | - |
| LongTec China Ventures | China, Shanghai |
| Luye Pharma | China, Shanghai |
| Metal VC | - |
| Pritzker Foundation | - |
| Startup Wise Guys SaaS | - |
| UB Ventures | Chiyoda, Japan |
| Valar Ventures | New York, New York, United States |
| Valence Capital Management | New York, New York, United States |
| Xinyuan Capital | China, Shanghai |
| Zhongjun Capital | Beijing, Beijing, China |
Discover 5 more decision makers Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Union Avatars-Linking Realities | 18 Oct 2024 | Barcelona, Catalonia, Spain | |||
Reveni | 03 Oct 2024 | Madrid, Madrid, Spain | |||
Caplena | $3M | 10 Jul 2024 | Zurich, Zurich, Switzerland | ||
ienai SPACE | $4M | 06 Jun 2024 | Madrid, Madrid, Spain | ||
Insurama | $6M | 13 May 2024 | A Coruña, Galicia, Spain | ||
Scaleup Finance | $8M | 26 Mar 2024 | Copenhagen, Hovedstaden, Denmark | ||
Connecta Therapeutics | $3M | 12 Feb 2024 | Barcelona, Catalonia, Spain | ||
Nanusens | 25 Sep 2023 | South Hams, England, United Kingdom | |||
All Structured Notes | $1M | 30 Jun 2023 | Madrid, Madrid, Spain |
– AmacaThera announced the close of an oversubscribed $10.3m Series A financing to support development of AMT-143, the company’s lead clinical asset, and pipeline expansion.
– The Series A round was led by Lumira Ventures and includes a global investor syndicate of existing investors, Viva BioInnovator and Sprout BioVentures, as well as new investors, BDC Capital Women in Technology (WIT) Venture Fund, Inveready, MBX Capital, CR Capital Management, StandUp Ventures, and MaRS IAF.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Union Avatars-Linking Realities | 18 Oct 2024 | Barcelona, Catalonia, Spain | |||
Reveni | 03 Oct 2024 | Madrid, Madrid, Spain | |||
Caplena | $3M | 10 Jul 2024 | Zurich, Zurich, Switzerland | ||
ienai SPACE | $4M | 06 Jun 2024 | Madrid, Madrid, Spain | ||
Insurama | $6M | 13 May 2024 | A Coruña, Galicia, Spain | ||
Scaleup Finance | $8M | 26 Mar 2024 | Copenhagen, Hovedstaden, Denmark | ||
Connecta Therapeutics | $3M | 12 Feb 2024 | Barcelona, Catalonia, Spain | ||
Nanusens | 25 Sep 2023 | South Hams, England, United Kingdom | |||
All Structured Notes | $1M | 30 Jun 2023 | Madrid, Madrid, Spain |
